chronic
infect
hepat
c
viru
hcv
seriou
global
health
problem
affect
million
peopl
worldwid
lead
liver
cirrhosi
hepatocellular
carcinoma
endstag
liver
diseas
current
treatment
chronic
hcv
infect
limit
combin
drug
therapi
highli
expens
seriou
side
effect
variabl
success
rate
differ
viral
genotyp
patient
popul
develop
vaccin
prevent
andor
cure
hcv
infect
paramount
import
natur
protect
infect
often
use
model
strategi
develop
new
vaccin
immun
mechan
correl
viral
clearanc
protect
hcv
infect
studi
extens
still
remain
unclear
number
studi
correl
natur
clearanc
hcv
infect
appear
vigor
multispecif
sustain
cell
respons
contrast
develop
chronic
infect
correl
weak
dysfunct
cellular
immun
respons
recent
metaanalysi
studi
publish
date
chimpanze
model
conclud
humor
immun
respons
also
play
determin
role
protect
chronic
hcv
infect
recent
studi
support
role
antibodi
beyond
neutral
viral
particl
extend
function
target
intracellular
pathogen
therefor
envis
success
prophylact
andor
therapeut
vaccin
strategi
would
encompass
gener
cellular
humor
respons
multipl
antigen
hcv
case
chronic
hcv
infect
report
patient
spontan
clear
infect
due
reactiv
function
cellular
immun
respons
howev
exact
mechan
spontan
revers
cellular
immun
respons
exhaust
andor
dysfunct
function
remain
elucid
sever
studi
hcvspecif
cell
expand
peripher
blood
tcell
popul
individu
previous
infect
hcv
among
hcv
expos
individu
clear
viru
acut
infect
due
induct
strong
multispecif
cellular
immun
respons
howev
known
preexist
heterolog
immun
role
hcv
clearanc
infect
influenza
viru
infect
shown
induc
narrow
heterolog
cellular
immun
respons
singl
epitop
hcv
antigen
adenovirus
ad
nonenvelop
icosahedr
virus
contain
doublestrand
dna
genom
kbp
belong
divers
famili
serotyp
dna
virus
call
adenovirida
infect
ocular
respiratori
gastrointestin
epithelium
divers
rang
host
induc
differ
level
immun
gain
immens
recognit
vaccin
antigen
deliveri
vehicl
sinc
initi
use
gene
therapi
also
proven
safe
effici
vaccin
vector
elicit
protect
immun
respons
transgen
antigen
mani
anim
human
clinic
studi
chimpanzeederiv
adenoviru
express
hcv
antigen
current
clinic
trial
studi
recombin
adenovirus
express
variou
individu
hcv
antigen
abil
modul
induc
hcvspecif
immun
vitro
human
cell
cultur
system
vivo
mice
studi
observ
immun
mice
control
nonrecombin
adenoviru
vector
ad
vector
express
hcv
antigen
also
induc
hcv
antigensspecif
cell
respons
address
puzzl
unexpect
observ
align
peptid
sequenc
differ
hcv
protein
variou
adenovir
protein
ad
protein
determin
level
homolog
protein
two
virus
intriguingli
discov
vari
degre
homolog
multipl
hcv
peptid
sequenc
core
f
protein
number
ad
protein
tabl
tabl
studi
conclus
demonstr
immun
mice
ad
vector
express
exogen
hcv
antigen
induc
robust
crossreact
humor
cellular
immun
respons
multipl
hcv
antigen
reduct
viral
titer
mice
infect
vaccinia
viru
express
recombin
hcv
antigen
surrog
model
corrobor
relev
crossreact
immun
respons
antivir
immun
intriguingli
normal
healthi
human
donor
known
histori
hcv
infect
seroposit
adspecif
igg
demonstr
presenc
crossreact
antibodi
cell
respons
multipl
hcv
antigen
studi
first
demonstr
heterolog
protect
immun
induc
ad
vector
hcv
studi
signific
implic
design
prophylact
therapeut
vaccin
hcv
addit
sinc
recombin
adenoviru
vector
forefront
candid
vaccin
sever
differ
pathogen
includ
hcv
ebola
viru
plasmodium
mycobacteria
influenza
viru
among
other
widespread
use
vaccin
could
significantli
impact
preval
natur
cours
hcv
infect
align
amino
acid
aa
sequenc
peptid
aa
long
aa
overlap
deriv
variou
hcv
antigen
core
f
genotyp
differ
ad
protein
use
bioinformat
softwar
clustalw
determin
homolog
score
tabl
summar
rang
homolog
hcvderiv
peptid
ad
protein
number
hcv
peptid
ad
protein
show
homolog
intriguingli
almost
compar
ad
protein
tabl
show
homolog
score
rang
sever
peptid
hcv
antigen
core
f
dataset
maximum
homolog
score
shown
hcv
peptid
core
f
similar
homolog
found
sequenc
hcv
antigen
show
low
homolog
lowest
number
ad
protein
data
shown
therefor
test
crossreact
immun
respons
induc
ad
vector
exclud
possibl
contamin
nonrecombin
ad
vector
stock
hcv
transgen
set
pcr
purifi
ad
dna
use
hcvspecif
primer
list
tabl
none
primer
set
specif
core
f
gene
hcv
abl
amplifi
hcv
gene
product
nonrecombin
ad
vector
dna
templat
fig
uninfect
hek
cell
lysat
recombin
adenovir
rad
vector
contain
individu
hcv
gene
use
neg
posit
control
respect
signific
homolog
hcv
deriv
peptid
ad
protein
sequenc
indic
adenovirus
might
induc
crossreact
immun
hcv
antigen
test
femal
mice
n
immun
intramuscularli
twice
day
interv
pfumous
ad
vector
ad
vector
poli
c
pb
prolifer
product
spleen
lymph
node
cell
determin
respons
hcv
core
protein
antigen
pool
select
peptid
list
dataset
core
peptid
peptid
peptid
peptid
fig
spleen
inguin
lymph
node
cell
ad
vector
immun
mice
demonstr
high
hcv
antigen
core
depend
prolifer
product
increas
coimmun
ad
vector
poli
c
adjuv
crossreact
prolifer
respons
select
individu
peptid
core
f
antigen
shown
supplementari
inform
fig
cell
prolifer
respons
also
examin
synthet
peptid
hcv
antigen
show
low
homolog
respons
obtain
background
data
shown
also
examin
induct
crossreact
igg
antibodi
hcv
protein
antigen
core
serum
sampl
obtain
immun
mice
fig
ad
vector
induc
signific
amount
crossreact
igg
hcv
antigen
coadministr
tlr
agonist
poli
c
enhanc
level
crossreact
antibodi
pbsimmun
mice
show
igg
bind
hcv
antigen
also
ad
vector
immun
mice
show
antibodi
bind
control
protein
antigen
rhsod
data
shown
confirm
high
prolifer
respons
observ
assay
due
actual
prolifer
crossreact
hcvspecif
cell
perform
cfse
dilut
assay
along
stain
marker
splenocyt
obtain
ad
vector
immun
mice
stimul
ex
vivo
hcv
protein
antigen
core
fig
select
repres
peptid
protein
fig
intriguingli
stimul
splenocyt
exhibit
remark
antigendepend
prolifer
crossreact
cell
demonstr
cytokin
produc
cultur
supernat
cell
perform
intracellular
cytokin
express
analys
splenocyt
obtain
ad
vector
immun
mice
stimul
ex
vivo
hcv
core
protein
antigen
fig
select
peptid
fig
splenocyt
mice
immun
pb
cultur
variou
hcv
peptid
protein
antigen
splenocyt
mice
immun
ad
vector
incub
medium
use
neg
control
fig
cell
ad
immun
mice
show
increas
express
simultan
upon
stimul
hcv
protein
compar
pb
immun
mice
fig
note
hcv
corestimul
cell
show
high
frequenc
express
cell
compar
hcv
antigen
howev
produc
cell
high
hcv
antigen
except
hcv
produc
cell
increas
fig
upon
stimul
hcv
core
peptid
crossreact
cell
show
enhanc
express
comparison
pb
group
fig
cell
notabl
high
peptid
use
vitro
stimul
fig
howev
frequenc
cell
express
increas
select
peptid
except
hcv
core
peptid
also
show
increas
frequenc
doubl
posit
cell
fig
cytotox
activ
crossreact
effector
cell
obtain
spleen
ad
vector
immun
mice
stimul
vitro
hcv
protein
antigen
core
polyprotein
examin
target
cell
load
pool
respect
hcv
antigen
peptid
differ
set
cfsestain
target
prepar
load
pool
hcv
antigen
peptid
core
peptid
peptid
peptid
peptid
list
dataset
peptid
peptid
load
differ
target
cultur
correspond
splenocyt
stimul
hcv
protein
antigen
result
show
splenocyt
induc
ad
vector
immun
potent
cytotox
effector
function
antigenspecif
manner
interestingli
ex
vivo
stimul
crossreact
effector
core
antigen
show
least
antigenspecif
cytotox
activ
compar
hcv
antigen
fig
demonstr
antivir
potenti
ad
vector
induc
crossreact
immun
respons
hcv
surrog
vachcv
infect
model
use
although
direct
model
hcv
infect
valuabl
model
assess
abil
induc
immun
kill
host
target
express
hcv
antigen
reduct
vachcv
viral
titer
model
critic
paramet
antivir
respons
hcv
mice
two
immun
ad
vector
without
poli
c
adjuv
challeng
wildtyp
vaccinia
wtvac
vacciniahcv
chimer
virus
vachcv
vachcv
five
day
challeng
viral
load
determin
ovari
individu
mice
fig
mice
immun
ad
vector
presenc
absenc
poli
c
significantli
p
reduc
vachcv
viral
load
comparison
pb
hek
cell
lysateimmun
mice
fig
contrast
viral
titer
wtvaccinia
challeng
mice
significantli
p
differ
hek
lysat
ad
vector
immun
mice
fig
result
provid
strong
evid
ad
vector
induc
crossreact
immun
specif
target
hcv
antigen
understand
induct
crossreact
immun
hcvnaiv
human
examin
adspecif
hcvspecif
crossreact
igg
healthi
human
blood
donor
n
fig
signific
direct
correl
presenc
adspecif
igg
hcv
spearman
r
p
valu
spearman
r
p
valu
fig
also
detect
crossreact
igg
hcv
core
antigen
howev
correl
antibodi
ad
hexonspecif
igg
fig
statist
signific
next
indic
crossreact
cellular
immun
respons
determin
intracellular
express
cell
subset
upon
ex
vivo
stimul
pbmc
hcv
peptid
pool
protein
antigen
day
interestingli
cell
healthi
donor
n
two
donor
provid
enough
blood
sampl
isol
pbmc
demonstr
induct
hcv
antigensspecif
andor
fig
overal
propens
induct
cell
upon
stimul
peptid
pool
four
hcv
antigen
protein
antigen
howev
number
donor
show
increas
express
cell
upon
stimul
hcv
antigen
fig
present
studi
demonstr
first
time
ad
vector
intrins
abil
induc
broad
robust
cellular
humor
immun
respons
number
hcv
structur
nonstructur
antigen
silico
sequenc
align
studi
tabl
tabl
dataset
exhibit
interest
unexpect
pattern
homolog
amino
acid
sequenc
hcv
ad
protein
sequenc
homolog
rang
homolog
report
hcv
core
peptid
epitop
show
greatest
amino
acid
homolog
largest
number
ad
protein
hcv
frameshift
protein
f
also
show
signific
level
homolog
ad
protein
result
present
fig
also
fig
provid
conclus
evid
ad
vector
induc
signific
level
crossreact
immun
respons
hcv
antigen
immun
respons
mediat
cell
cover
broad
rang
hcv
peptid
epitop
also
show
heterolog
effector
cell
induc
ad
vector
immun
possess
strong
cytotox
effector
function
fig
heterolog
immun
term
use
immun
respons
induc
one
viru
confer
immun
anoth
unrel
viru
andor
antigen
inde
report
show
induct
crossreact
cell
respons
among
unrel
virus
adenoviru
hepat
c
viru
evolutionarili
unrel
differ
host
cell
specif
contain
genom
dsdna
rna
respect
howev
induct
heterolog
immun
requir
entir
cell
epitop
homolog
immun
result
similar
amino
acid
sequenc
small
stretch
peptid
andor
promiscu
cell
receptor
tcr
shown
amino
acid
cell
epitop
activ
particip
interact
tcr
stronger
associ
peptidemhc
tcr
provid
costimulatori
molecul
mhc
molecul
therefor
quit
possibl
tcr
still
recogn
peptid
noncontact
amino
acid
replac
biochem
similar
even
differ
amino
acid
mhc
class
ii
molecul
bind
present
varieti
peptid
differ
amino
acid
composit
properti
mhc
molecul
tcr
necessari
process
respond
vast
pool
epitop
origin
huge
number
pathogen
andor
antigen
variou
studi
show
cell
promiscu
cell
peptid
epitop
recognit
also
mhc
class
ii
peptid
bind
pocket
flexibl
mhc
class
peptidebind
pocket
higher
level
promiscu
occur
cell
level
flexibl
within
peptidemhc
ii
bind
allow
greater
lessrestrict
cell
respons
properti
physiolog
relev
cell
help
requir
gener
humor
effector
cell
respons
studi
also
shown
amino
acid
peptid
epitop
substitut
amino
acid
similar
biochem
properti
still
recogn
cell
clone
addit
cell
clone
could
intrins
crossreact
other
outbr
human
popul
repertoir
peptid
present
cell
recognit
becom
even
broader
due
codomin
express
mhc
molecul
therefor
individu
may
show
higher
heterolog
immun
certain
antigen
individu
interest
aspect
ad
vector
induc
heterolog
immun
emerg
respons
core
antigen
hcv
previous
report
mice
immun
recombin
ad
vector
express
whole
hcv
core
protein
gener
corespecif
cell
respons
due
immunosuppress
effect
contrast
current
studi
unexpectedli
found
ad
vector
without
transgen
abl
induc
robust
core
antigen
specif
humor
cellular
immun
respons
due
high
degre
homolog
multipl
corederiv
peptid
sequenc
variou
adenoviru
protein
could
adenoviru
encod
complet
sequenc
hcvcore
rather
exhibit
homolog
short
peptid
sequenc
therefor
coreinduc
immun
suppress
appar
interestingli
howev
corestimul
effector
cell
show
significantli
less
kill
activ
effector
fig
reason
clear
yet
tlr
agonist
poli
c
engag
receptor
trigger
signal
result
upregul
sever
costimulatori
molecul
cytokin
antigen
present
cell
also
cell
enhanc
antigenspecif
respons
studi
coadministr
poli
c
along
ad
vector
boost
intrins
heterolog
immun
ad
vector
multipl
hcv
antigen
endors
ad
vector
mediat
induct
heterolog
immun
hcv
fig
humor
immun
respons
mediat
b
cell
produc
antibodi
pathogenderiv
antigen
antibodi
recogn
linear
peptid
epitop
conform
epitop
crossreact
antibodi
respons
expect
contribut
linear
peptid
epitop
contain
ident
biochem
similar
amino
acid
fab
bind
site
therefor
hcv
ad
vector
protein
show
high
level
homolog
differ
site
protein
probabl
crossreact
abbind
epitop
high
data
suggest
antibodi
produc
respons
ad
vector
immun
also
show
crossreact
hcv
antigen
enhanc
upon
coimmun
poli
c
fig
addit
induc
cell
antibodi
respons
data
clearli
demonstr
antivir
potenti
heterolog
immun
induc
ad
antigen
significantli
reduc
viral
load
vachcv
challeng
mice
wildtyp
vaccinia
challeng
mice
fig
use
adjuv
ad
vector
enhanc
crossreact
antivir
immun
fig
whether
cellular
andor
humor
arm
crossreact
immun
confer
viral
reduct
advanc
model
hcv
remain
determin
adenovirus
commonli
infect
human
also
shown
exist
persist
normal
gut
flora
therefor
sought
detect
hcvspecif
crossreact
immun
respons
human
preexist
immun
ad
intriguingli
observ
healthi
hcvnaiv
human
donor
n
seroposit
antiad
igg
fig
demonstr
crossreact
hcvspecif
humor
n
cellular
n
immun
fig
interestingli
major
donor
cell
show
higher
induct
compar
upon
stimul
differ
hcv
antigen
minor
donor
show
higher
level
express
compar
cell
result
repres
exist
two
discreet
cours
natur
crossreact
cellular
immun
respons
hcv
antigen
human
preexist
adspecif
immun
reason
two
cours
clear
could
depend
upon
hla
type
cell
repertoir
andor
environment
factor
howev
specul
exposur
individu
hcv
may
also
lead
distinct
pattern
immun
respons
culmin
either
acuteselfclear
chronic
infect
predisposit
toward
develop
chronic
hcv
infect
major
case
result
intrigu
suggest
potenti
impact
ad
immun
natur
cours
chronic
vs
acuteclear
hcv
infect
albeit
small
number
individu
prospect
immunolog
studi
larg
cohort
individu
requir
fulli
predict
correl
ad
immun
viral
clearanc
vs
persist
upon
exposur
hcv
conclus
ad
vector
intrins
abil
induc
broadli
reactiv
immun
highli
conserv
hcv
antigen
across
genotyp
may
potenti
use
therapeuticprophylact
pangenotyp
vaccin
hcv
infect
even
without
addit
hcv
transgen
rare
human
nonhuman
adenovirus
develop
ad
vectorbas
vaccin
avoid
issu
preexist
immun
howev
strategi
complet
rule
preexist
inter
intraspeci
crossreact
antiadenovir
immun
fact
shown
recent
human
subject
screen
seroposit
chimp
ad
viru
seroposit
rare
human
ad
viru
contrast
seroposit
preval
human
ad
viru
adenovirusspecif
cell
immun
conserv
epitop
shown
across
variou
human
serotyp
also
across
speci
observ
homolog
hcv
epitop
differ
adenovirus
span
across
number
adenovir
protein
thu
possibl
extend
number
uncommon
human
nonhuman
adenovirus
heterolog
immun
doubleedg
sword
modul
breadth
cell
repertoir
influenc
memori
cell
pool
andor
immunedomin
specif
epitop
lead
enhanc
diminish
immun
respons
pathogen
crossreact
immun
respons
explain
spontan
reactiv
hcvspecif
function
immun
respons
viral
clearanc
also
explain
case
hcvspecif
memori
cell
individu
remain
establish
howev
whether
preexist
immun
adenovirus
preval
use
ad
vector
vaccin
diseas
shape
cours
natur
infect
hcv
human
popul
fifteen
twenti
amino
acid
long
sequenc
variou
hcv
antigen
genotyp
core
f
compar
human
adenoviru
protein
sequenc
tabl
sequenc
align
use
clustalw
softwar
onlin
version
sequenc
homolog
document
pairwis
similar
homolog
score
heat
map
prepar
microsoft
excel
present
distribut
hcv
antigen
peptid
homolog
across
differ
adenoviru
protein
pairwis
score
align
region
number
ident
two
sequenc
divid
length
align
calcul
percentag
score
mean
homolog
mean
homolog
align
sequenc
number
adenoviru
protein
show
variou
level
homolog
calcul
heat
map
score
summar
tabl
see
dataset
detail
replicationincompet
human
adenoviru
transgen
insert
amplifi
titrat
human
embryon
cell
line
sourc
atcc
crl
transform
adenoviru
gene
cat
ae
qbiogen
inc
ca
usa
provid
complementar
viru
product
recombin
adenovirus
rad
express
hcv
antigen
core
radcor
f
radf
prepar
report
earlier
us
dna
purifi
ad
radcor
vector
stock
briefli
pfu
vector
taken
individu
tube
dna
prepar
use
highpur
viral
nucleic
acid
kitr
cat
roch
appli
bio
pcr
reaction
set
templat
dna
obtain
prepar
use
total
reaction
volum
consist
pcr
buffer
dntp
primer
forward
revers
list
tabl
unit
taq
polymeras
pcr
tube
contain
reaction
mixtur
incub
thermocycl
initi
denatur
amplif
cycl
sec
sec
sec
pcr
amplif
product
run
agaros
gel
volt
resolv
amplif
product
along
kb
size
quick
load
dna
ladder
cat
neb
biolab
germani
tolllik
agonist
poli
c
cat
sigmaaldrich
st
loui
mo
usa
use
adjuv
immun
ad
vector
six
seven
weekold
femal
mice
purchas
charl
river
laboratori
charl
river
canada
immun
twice
intramuscularli
interv
use
optim
dose
pfumous
ad
presenc
absenc
adjuv
poli
c
mice
euthan
day
second
immun
variou
tissu
sampl
eg
spleen
inguin
lymph
node
ovari
serum
etc
collect
eight
day
second
immun
mice
euthan
spleen
andor
inguin
lymph
node
collect
spleen
pool
replic
ground
singl
cell
suspens
filter
falcon
nylon
cell
strainer
cell
resuspend
ml
media
pass
equilibr
nylon
wool
column
column
wash
min
incub
flow
contain
splenic
cell
cell
use
experi
cell
lymph
node
also
ground
singl
cell
suspens
use
assay
prolif
respons
measur
triplic
cultur
flatbottom
microtit
plate
total
cell
immun
mice
apc
spleen
cell
unimmun
mice
irradi
rad
mix
differ
hcvderiv
protein
core
sod
polyprotein
polyprotein
control
protein
rhsod
kindli
provid
chironnovarti
synthet
hcvderiv
peptid
see
dataset
differ
concentr
describ
fig
legend
cell
prolifer
assess
radioact
incorpor
assay
detail
methodolog
cell
prolifer
assay
report
previous
us
level
assess
cultur
supernat
collect
cell
prolifer
assay
use
mous
elisa
kit
suppli
ebiosci
cat
ebiosci
inc
san
diego
usa
elisa
perform
accord
manufactur
instruct
plate
read
data
analyz
fluostar
elisa
reader
bmg
labtech
gmbh
ortenberg
germani
cytokin
concentr
per
ml
cultur
supernat
determin
multipli
calcul
concentr
dilut
factor
averag
concentr
pgml
duplic
well
plot
graph
shown
serum
prepar
blood
immun
mice
store
requir
hcv
antigenspecif
crossreact
igg
antibodi
ad
vector
immun
mice
measur
plate
coat
overnight
hcv
antigen
core
next
day
block
bsa
room
temperatur
hour
serial
dilut
serum
sampl
ad
plate
replic
incub
room
temperatur
hour
applic
serum
antimous
igg
label
alkalin
phosphatas
ap
cat
southern
biotech
alabama
usa
ad
plate
incub
hour
color
develop
ad
pnpp
substrat
cat
southern
biotech
alabama
usa
plate
wash
incub
step
absorb
read
use
fluostar
optima
elisa
reader
bmg
labtech
gmbh
ortenberg
germani
od
valu
hcv
antigenco
plate
correct
background
od
valu
sodcoat
plate
plot
graph
shown
mous
splenocyt
cultur
hcv
protein
antigen
peptid
day
media
supplement
fetal
bovin
serum
fifth
day
cell
harvest
count
cell
per
group
stain
cell
marker
perform
intracellular
cytokin
stain
splenocyt
cultur
day
hcv
antigen
treat
ionomycin
phorbol
pma
ngml
brefeldin
cat
hour
subsequ
stain
fluorochrom
label
antibodi
purchas
ebiosci
inc
san
diego
usa
extracellular
lineag
marker
pe
cat
apc
cat
apc
efluor
cat
intracellular
cytokin
pe
cat
fitc
cat
cell
prolifer
use
cfse
dilut
assay
splenocyt
enrich
cell
use
nylon
wool
column
stain
cfse
cat
sigmaaldrich
st
loui
mo
usa
ml
cell
suspens
minut
room
temperatur
cfse
stain
cell
wash
pb
contain
fetal
bovin
serum
count
plate
plate
hcv
core
antigen
repres
peptid
equal
number
syngen
splenocyt
apc
cell
cultur
four
day
stain
cell
marker
cell
stain
isotyp
control
antibodi
correspond
fluorochrom
pe
cat
apc
cat
apc
efluor
cat
pe
fitc
cat
purchas
ebiosci
inc
san
diego
usa
use
exclud
nonspecif
bind
stain
cell
run
bd
fac
canto
bd
bioscienc
san
jose
ca
usa
data
analyz
use
fc
express
softwar
de
novo
softwar
glendal
ca
usa
splenocyt
harvest
ad
vector
immun
mice
stimul
vitro
hcv
protein
antigen
core
polyprotein
day
target
cell
incub
correspond
hcv
peptid
core
peptid
peptid
peptid
peptid
peptid
mixtur
peptid
core
overnight
next
day
peptid
load
cell
cultur
effector
effector
target
ratio
hour
cfselabel
live
target
quantifi
flow
cytometri
subtract
background
cfselabel
target
get
number
kill
target
empti
peptid
load
target
use
neg
control
eight
day
second
immun
ad
vector
ad
vector
poli
c
pb
mice
challeng
pfu
vachcv
chimer
viru
includ
core
antigen
hcv
includ
antigen
hcv
kindli
provid
dr
alfr
princ
ny
usa
wildtyp
vaccinia
wtvac
contain
hcv
antigen
viru
intraperiton
five
day
viru
challeng
mice
euthan
ovari
remov
homogen
freezethaw
three
time
pb
homogen
sampl
store
use
viral
titer
serial
dilut
sampl
ovari
homogen
ad
duplic
well
plate
contain
confluent
monolay
mous
lymphoma
cell
line
atcc
crl
incub
minut
subsequ
unbound
viru
remov
fresh
dmem
medium
cat
gibco
invitrogen
ny
usa
supplement
fb
ad
plate
incub
hour
time
medium
remov
plaqu
fix
use
formaldehyd
cat
fisher
scientif
nj
usa
room
temperatur
minut
plate
wash
pb
monolay
stain
minut
crystal
violet
cat
sigmaaldrich
compani
mo
usa
follow
wash
plaqu
count
averag
multipli
dilut
factor
determin
viral
loadmous
data
present
reduct
viral
load
calcul
formula
mean
viral
titer
control
grouptit
immun
group
mean
viral
titer
control
group
x
control
group
viral
titer
rang
pfumous
pfumous
peripher
blood
sampl
collect
healthi
human
donor
sex
known
histori
hcv
infect
collect
blood
process
immedi
pbmc
isol
use
ficol
gradient
separ
upper
plasma
layer
frozen
aliquot
igg
elisa
middl
pbmc
layer
collect
wash
frozen
use
antiad
igg
hexonspecif
antibodi
detect
evalu
plasma
donor
use
ibl
adenoviru
igg
elisa
kit
cat
iblamerica
inc
minneapoli
mn
usa
plasma
sampl
assay
dilut
duplic
accord
manufactur
procedur
hcv
antigensspecif
crossreact
igg
determin
elisa
briefli
elisa
plate
coat
recombin
hcv
antigen
core
control
protein
sod
superoxid
dismutas
overnight
follow
block
bsa
bovin
serum
albumin
hour
plasma
sampl
ad
triplic
incub
hour
room
temperatur
bind
antigenspecif
human
igg
detect
ad
antihuman
igg
label
alkalin
phosphatas
ap
cat
southern
biotech
alabama
usa
hour
follow
addit
pnpp
substrat
cat
southern
biotech
alabama
usa
minut
plate
wash
pbst
pb
incub
step
absorb
od
measur
nm
correct
background
subtract
od
valu
obtain
control
sodcoat
plate
absorb
measur
use
fluostar
optima
elisa
reader
bmg
labtech
gmbh
ortenberg
germani
statist
analys
od
valu
antiad
igg
elisa
arrang
increas
order
correl
correspond
od
valu
antihcv
igg
correl
coeffici
calcul
spearman
rank
correl
frozen
pbmc
thaw
wash
warm
pb
twice
count
cultur
aimv
serum
free
medium
cat
gibco
life
technolog
ny
usa
plate
hour
hcv
pool
synthet
peptid
core
peptid
peptid
peptid
peptid
individu
protein
core
ad
plate
concentr
peptid
select
basi
high
sequenc
homolog
ad
protein
detect
crossreact
respons
mous
experi
phytohemagglutinin
pha
mediatr
cell
consid
posit
neg
control
respect
three
day
incub
cell
treat
brefeldin
cat
ebiosci
inc
san
diego
ca
usa
hour
stain
extracellular
lineag
marker
use
fluorochromelabel
antibodi
purchas
ebiosci
inc
san
diego
usa
efluor
cat
fitc
cat
pe
cat
intracellular
cytokin
apc
cat
pecyanin
cat
stain
cell
measur
bd
fac
canto
data
analyz
use
fac
diva
softwar
cell
popul
gate
subset
evalu
separ
express
pbmc
stain
isotyp
antibodi
correspond
fluorochrom
cat
purchas
ebiosci
inc
san
diego
usa
use
exclud
nonspecif
bind
percent
increas
cytokin
express
calcul
formula
antigen
treat
cell
media
control
media
control
x
percentag
cell
posit
media
group
rang
differ
donor
data
analyz
graphpad
prism
softwar
graphpad
softwar
inc
ca
usa
two
tail
student
ttest
use
determin
signific
differ
two
group
pvalu
less
consid
statist
signific
anim
experi
approv
univers
alberta
anim
care
use
committe
protocol
number
aup
till
june
accord
canadian
council
anim
care
guidelin
written
inform
consent
obtain
adult
blood
donor
procedur
relat
human
tissu
approv
number
till
nov
accord
univers
alberta
human
research
ethic
board
hreb
